Table 5.

Arterial thromboembolic and haemorrhagic events for second dose BNT162b2 vaccine.

Time-period post vaccination	Number of events	Number of person days	Incidence rate ratio (95% confidence interval)
Arterial thromboembolic events
Baseline	30,576	15,194,492	1.0
Clearance	681	357,332	0.77 (0.71–0.83)
0–6 days	411	180,286	0.89 (0.81–0.99)
7–13 days	452	176,569	1.0 (0.92–1.10)
14–20 days	372	175,370	0.83 (0.75–0.93)
21–27 days	483	174,258	1.1 (1.0–1.20)
0–27 days	1718	706,483	0.96 (0.91–1.0)
Haemorrhagic events
Baseline	2388	1,269,064	1.0
Clearance	72	32,345	1.1 (0.86–1.39)
0–6 days	29	16,215	0.88 (0.61–1.27)
7–13 days	27	16,111	0.82 (0.56–1.20)
14–20 days	31	16,010	0.95 (0.66–1.36)
21–27 days	32	15,916	0.99 (0.69–1.41)
0–27 days	119	64,252	0.91 (0.75–1.10)